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Background and purpose   Controversies still exist regarding the 
best surgical procedure in the treatment of periprosthetic infec-
tion  after  total  hip  arthroplasty  (THA).  Based  on  data  in  the 
Norwegian Arthroplasty Register (NAR), we have compared the 
risk of re-revision after 4 different surgical procedures: 2-stage 
with exchange of the whole prosthesis, 1-stage with exchange of 
the whole prosthesis, major partial 1-stage with exchange of stem 
or cup, and minor partial 1-stage with exchange of femoral head 
and/or acetabular liner.
Methods   Between 1987 and 2009, 124,759 primary THAs were 
reported to the NAR, of which 906 (0.7%) were revised due to 
infection. Included in this study were the 784 revisions that had 
been performed by 1 of the 4 different surgical procedures. Cox-
estimated survival and relative revision risks are presented with 
adjustment for differences among groups regarding gender, type 
of fixation, type of prosthesis, and age at revision. 
Results   2-stage procedures were used in 283 revisions (36%), 
1-stage  in  192  revisions  (25%),  major  partial  in  129  revisions 
(17%), and minor partial in 180 revisions (23%). 2-year Kaplan-
Meier survival for all revisions was 83%; it was 92% for those re-
revised by 2-stage exchange procedure, 88% for those re-revised 
by 1-stage exchange procedure, 66% for those re-revised by major 
partial exchange procedure, and it was 76% for those re-revised 
by minor partial exchange. Compared to the 2-stage procedure 
and with any reason for revision as endpoint (180 re-revisions), 
the risk of re-revision increased 1.4 times for 1-stage (p = 0.2), 4.1 
times for major partial exchange (p < 0.001), and 1.5 times for 
minor partial exchange (p = 0.1). With infection as the endpoint 
(108 re-revisions), the risk of re-revision increased 2.0 times for 
1-stage exchange (p = 0.04), 6.0 times for major partial exchange 
(p < 0.001), and 2.3 times for minor partial exchange (p = 0.02). 
Similar results were found when the analyses were restricted to 
the period 2002–2009. 
Interpretation   In the Norwegian Arthroplasty Register, the sur-
vival after revision of infected primary THA with 2-stage implant 
exchange was slightly superior to that for 1-stage exchange of the 
whole prosthesis. This result is noteworthy, since 2-stage proce-
dures are often used with the most severe infections. However, 
debridement with exchange of head and/or liner but with reten-
tion of the fixed implant (minor revision) meant that there was a 
76% chance of not being re-revised within 2 years. 

 The risk of periprosthetic infection after total hip arthroplasty 
(THA) has decreased from 5–10% in the late 1960s to around 
1% today (Lidgren 2001, Lidgren et al. 2003, Zimmerli and 
Ochsner 2003, Dale et al. 2009, Walenkamp 2009, Ong et al. 
2009, Urquhart et al. 2010). In the last few years, however, 
some reports have indicated that there is an increasing inci-
dence of revisions for infected THA (Kurtz et al. 2008, Dale 
et al. 2009, Pedersen et al. 2010).
The optimum treatment of deep infection remains controver-
sial (Toms et al. 2006). 2-stage exchange requires a minimum 
of 2 surgical procedures and a substantial period of reduced 
mobility. Removal of a well-fixed cemented prosthesis may 
also result in degradation of the bone stock and perioperative 
fracture (Langlais 2003, Ong et al. 2009, Bejon et al. 2010). 
A procedure with debridement, antibiotics, and implant reten-
tion (DAIR) with or without exchange of removable parts (i.e. 
liner and/or head), which is technically less demanding, could 
therefore be an attractive option for treatment of early deep 
infections, especially in elderly or frail patients (Giulieri et al. 
2004, Trebse et al. 2005, Toms et al. 2006, Byren et al. 2009).
In  this  paper,  based  on  the  data  in  the  Norwegian 
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assigned to each resident of Norway, the information from 
the primary THA is linked to any subsequent revisions in the 
registry. Revision is defined as surgical removal or exchange 
of the whole implant or part of it. Information in the form 
includes the identity of the patient, the date of the operation, 
the indications for surgery, the type of prosthesis (modular or 
monoblock), the type of fixation (uncemented, cemented with 
antibiotic-loaded cement, or cemented with cement without 
antibiotic), and the duration of the operation. 
From the start of the Register in September 1987 to the end 
of December 2009, 124,759 primary THAs were reported. 
Included in the present study were first revisions of THAs per-
formed due to deep infection. The decision as to the diagnosis 
of infection was made by the reporting orthopedic surgeon 
immediately postoperatively and therefore before the results 
of the peroperative culture were known. The postoperative 
systemic antibiotic treatment of the infection was not reported 
to the registry. The risk of re-revision of these revisions was 
compared for the following 4 types of surgical procedures 
for deep infection: 2-stage exchange revision in which the 
whole prosthesis was exchanged in a 2-stage procedure (fol-
lowing the removal of the infected implant, a new implant 
was inserted in a second stage), 1-stage exchange revision 
in which the whole prosthesis was exchanged in 1 operation, 
major partial 1-stage revision including exchange of the stem 
or the cup, or minor partial 1-stage revision with exchange 
of only the femoral head and/or the acetabular liner. Due to 
some changes in the strategy for surgical treatment of infected 
THAs in Norway in recent years, separate analyses were con-
ducted for revisions performed during the latter part of the 
study period (2002–2009). 
In addition, separate analyses were performed for revisions 
performed with time intervals from the primary THA to the 
revision of the infected implant of less than 3 weeks, of 3–12 
weeks, and of more than 12 weeks.
Statistics 
Survival analysis was performed using the Kaplan-Meier and 
Cox regression methods. Patients who had died or emigrated 
during follow-up were identified from files provided by Sta-
tistics Norway, and the follow-up time for prostheses in these 
patients was censored at the date of death or emigration. A Cox 
multiple regression model was used to study relative revision 
risks (failure-rate ratios) among the 4 types of revision proce-
dures, with adjustments for possible influence of gender, type 
of fixation (uncemented or cemented with or without antibi-
otic), type of prosthesis (monoblock, modular), and age of the 
patient at revision. Estimates from the Cox analyses with the 
4 types of procedures as strata factors were used to construct 
adjusted survival curves. Assessments of proportionality in 
the Cox models were performed using log minus log of the 
adjusted survival curves, and the proportionality assumptions 
were fulfilled. SPSS software version 17.0 was used for the 
analyses.
 
Results
Of the 124,759 primary THAs in the NAR, 9,563 (7.7%) were 
revised with removal or exchange of the whole prosthesis or 
parts of it. Of these, 906 were revised due to infection, i.e. 
0.7% of all primary THAs or 9.5% of all first revisions (Figure 
Figure 1. Flow chart showing the entire THA cohort and the different subgroups of surgical revision 
procedures (number and percentage) for revisions performed for any cause and due to infection.
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sion after the first surgical revision 
for deep infection of a primary THA 
by one of the following 4 surgical 
procedures: 2-stage exchange of the 
whole prosthesis, 1-stage exchange 
of the whole prosthesis, major par-
tial 1-stage with exchange of stem 
or  acetabulum,  and  minor  partial 
1-stage with exchange of acetabular 
liner and/or femoral head (Trampuz 
and Zimmerli 2006). 
Patients and methods 
The  Norwegian  Arthroplasty  Reg-
ister  is  a  nationwide  registry  that 
was established in 1987. Each THA, 
primary  or  revision,  performed  in 
Norway is reported individually by 
the surgeon by completing a standard 
form  (Havelin  et  al.  2000).  Using 
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1). 122 revisions were permanent removals of the implant 
without later insertion of a new prosthesis (Girdlestone proce-
dures). These were excluded in the subsequent analyses. The 
remaining 784 infected THAs were revised in the following 
ways: 2-stage exchange of the whole prosthesis (n = 283), 
1-stage exchange of the whole prosthesis (n = 192), major 
partial 1-stage exchange of the stem or the acetabulum (n = 
129), or minor partial 1-stage with exchange of the femoral 
head and/or the acetabular liner only (n = 180) (Table 1 and 
Figure 1). 
Of these 784 revisions, 180 (23%) were re-revised: 13% of 
them with a 2-stage procedure, 20% with a 1-stage procedure, 
50% with major partial, and 22% with minor partial (Figure 
1). 2-year Kaplan-Meier survival for all revisions was 83%; 
for 2-stage exchange it was 92%, for 1-stage exchange it was 
88%, for major partial exchange it was 66%, and for minor 
partial exchange it was 76% (Table 2).
With any reason for re-revision as endpoint in the Cox anal-
yses, and compared to the 2-stage procedure, the risk of re-
revision was 1.4 times higher for 1-stage exchange (p = 0.2), 
4.1 times higher for major partial exchange (p < 0.001), and 
1.5 times higher for minor partial exchange (p = 0.1) (Figure 
2A and Table 2). 
Of the 180 re-revisions, 108 (60%) were performed due to 
infection. For the 2-stage procedures, the re-revisions were 
performed due to infection in 39% of the cases (15 of 38); for 
the 1-stage procedures they were performed due to infection 
in 58% of cases (22 of 38); for major partial exchange they 
were performed due to infection in 58% of cases (37 of 64); 
and for minor partial exchange they were performed due to 
infection in 85% of cases (34 of 40). 
With infection as endpoint in the Cox analyses, compared 
to the 2-stage procedure, the risk of re-revision was 2.0 times 
higher for 1-stage exchange (p = 0.04), 6.0 times higher for 
major partial exchange (p < 0.001), and 2.3 times higher for 
minor partial exchange (p = 0.02) (Figure 2B and Table 2). 
The time interval between the primary THA and the first 
revision due to infection was shorter for the minor partial 
exchange than for the other procedures (Figure 3 and Table 1). 
The period 2002–2009
In recent years, there has been a change in strategy for sur-
Table 1. Descriptive data on 2-stage revision, 1-stage revision, major partial 1-stage exchange (i.e. exchange of stem or cup), and minor 
partial 1-stage exchange (i.e. exchange of head and/or liner) for infected THAs in the period 1987–2009
Type of revision  No. of  Mean age at  Females %  Mean duration of  Mean interval: operation
  revisions (%)  revision (years) a    operation (min) a  to revision (years) a
2-stage   283 (36%)  71 (9; 34–88)   52%   320 (91; 155–780) b   2.9 (3.0; 0.1–16)
1-stage   192 (25%)  72 (9; 42–90)  45%  167 (59; 65–380)    p < 0.001  2.9 (3.0; 0.0–15)    p = 1.00
Major partial exchange  129 (17%)  70 (11; 31–89)  51%  139 (49; 35–300)    p < 0.001  3.1 (3.4; 0.0–19)    p = 1.00
Minor partial exchange  180 (23%)  72 (11; 38–92)  54%    94 (33; 35–320)    p < 0.001  0.7 (2.0; 0.0–13)    p < 0.001
Total  784 (100%)  71 (10; 31–92)  51%  202 (115; 35–780 )  2.4 (3.0; 0.0–19) 
a Values are mean (SD; min–max)
b The duration of operation for 2-stage revision includes first stage with removal of the implant (171 (62; 45–445)) and second stage with re-
implantation (149 (48; 35–450)). 
Table 2. Results of the first revision for infected THA in the period 1987–2009 with any reason for revision and 
with infection as endpoints in the analyses for 2-stage revision, 1-stage revision, major partial 1-stage exchange 
(i.e. exchange of stem or cup), and minor partial 1-stage exchange (i.e. exchange of head and/or liner). Number 
of THAs, number of re-revisions (with complete dataset in the Cox analyses), Kaplan-Meier (KM) 2-year revision 
percentages, Cox relative revision risk (RR) (with 2-stage revision as reference), 95% confidence interval for RR, 
and p-value
Endpoint in the analyses  THA (%)  Re-revisions  2-year KM survival  RR a   95% CI  p-value
Any reason for revision:  784 (100%)  180 (23%)  83%     
  2-stage revision  283 (36%)    38 (13%)  92%  1  –  –
  1-stage revision  192 (25%)    38 (20%)  88%  1.4  0.9–2.1  0.2
  Major partial exchange  129 (17%)    64 (50%)  66%  4.1  2.8–6.2  < 0.001
  Minor partial exchange  180 (23%)    40 (22%)  76%  1.5  0.9–2.5  0.1
Infection:  784 (100%)  108 (14%)  88%     
  2-stage revision  283 (36%)    15 (5%)  96%  1  –  –
  1-stage revision  192 (25%)    22 (11%)  92%  2.0  1.1–3.9  0.04
  Major partial exchange  129 (17%)    37 (29%)  74%  6.0  3.3–11.0   < 0.001
  Minor partial exchange  180 (23%)    34 (19%)  80%  2.3  1.2–4.5  0.02
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gical revision of infected THAs, with a marked increase in 
minor partial exchange from 2002, and this procedure has now 
become the most common one for revision of infected THAs 
(Figure 4). Thus, subanalyses restricted to the period 2002–
2009 were conducted and descriptive data are given in Table 3. 
Of the 489 first revisions due to infection in 2002–2009, 
100 (20%) were reported to be re-revised (for any reason) 
during this shorter follow-up until the end of 2009, i.e. up 
to 8 years. For those treated with the 2-stage procedure, 9% 
were  re-revised;  for  the  1-stage  procedure,  13%  were  re-
revised; for the major partial procedure, 56% were re-revised; 
and  for  the  minor  partial  procedure,  23%  were  re-revised. 
2-year Kaplan-Meier survival for revisions performed in the 
period 2002–2009 was about the same as for the whole period 
(1987–2009), but there was inferior survival for major partial 
exchange (Table 4). 
With any reason for re-revision as endpoint, for the period 
2002–2009 and compared to 2-stage exchange revision, the 
risk of re-revision was 1.3 times higher for 1-stage exchange 
(p  =  0.5),  7.4  times  higher  for  major  partial  exchange 
(p < 0.001), and 1.9 times higher for minor partial exchange 
(p = 0.05) (Table 4 and Figure 5A). 
For the period 2002–2009, 77 of the 100 re-revisions were 
performed  due  to  infection:  2-stage  re-revisions  were  per-
formed in 9 hips, 1-stage in 8, major partial in 26, and minor 
partial in 34 hips. With infection as endpoint for re-revision, 
the risk of re-revision for 1-stage exchange was 1.6 times 
higher (p = 0.4), it was 9.0 times higher for major partial 
exchange (p < 0.001), and 2.5 times higher for minor partial 
exchange (p = 0.03) (Table 4 and Figure 5B). 
Figure 2. Cox-adjusted survival curves for first revision due to infected THA for the whole period 1987–2009 with any reason for re-revision (panel 
A) and infection (panel B) as endpoints in the analyses for 2-stage revision, 1-stage revision, major partial 1-stage exchange (i.e. exchange of 
stem or cup), and minor partial 1-stage exchange (i.e. exchange of head and/or liner). 
Survival – re-revision for any reason as endpoint 1987–2009 
Minor partial Two-stage
Single-stage
Major partial
A. Years after index operation 
Minor partial
Two-stage
Single-stage
Major partial
B.
Survival – re-revision for infection as endpoint 1987–2009 
Years after index operation 
Figure 3. Interval between the primary THA and the first revision per-
formed in the period 1987–2009, for 2-stage revision, 1-stage revision, 
and major and minor partial exchange. 
 
Minor partial
Two-stage
Single-stage
Major partial
Not revised
Years between primary THA and revision for infection
Figure  4.  Number  of  first  revisions  per  year  for  THAs  carried  out 
between 1987 and 2009 with the 2-stage procedure (283 revisions), 
1-stage procedure (192 revisions), major partial 1-stage exchange (i.e. 
exchange of stem or cup) (129 revisions), and minor partial 1-stage 
exchange (i.e. exchange of the liner or head) (180 revisions).
Minor partial (n=180)
Two-stage (n=283)
Single-stage (n=192)
Major partial (n=129)
No. of revisions
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Revisions with uncemented and cemented THAs 
For  the  whole  period  1987–2009,  201  revisions  were  per-
formed with uncemented implants both in the femur and in the 
acetabulum and 252 revisions were performed with antibiotic-
loaded cement in both components. Compared to uncemented 
implants and with any reason for re-revision as endpoint in the 
Table 4. Results of the first revision for infected THA in the period 2002–2009 with any reason for re-revision and 
with infection as endpoints in the analyses for 2-stage revision, 1-stage revision, major partial 1-stage exchange 
(i.e. exchange of stem or cup), and minor partial 1-stage exchange (i.e. exchange of head and/or liner). Number 
of THAs, number of re-revisions (with complete dataset in the Cox analyses), Kaplan-Meier (KM) 2-year revision 
percentages, Cox relative revision risk (RR) (with 2-stage revision as reference), 95% confidence interval for RR, 
and p-value 
Endpoint in the analyses  THA (%)  Re-revisions  2-year KM survival  RR a   95% CI  p-value
Any reason for revision:  489 (100%)   100 (23%)  83%
  2-stage revision  164 (34%)  15 (9%)  94%  1  –  –
  1-stage revision    86 (18%)  11 (13%)  87%  1.3  0.6–2.8  0.5
  Major partial exchange    61 (12%)  34 (56%)  57%  7.4  4.0–13.8  < 0.001
  Minor partial exchange  178 (36%)  40 (22%)  78%  1.9  1.0–3.8  0.05
Infection:  489 (100%)  77 (16%)  86%     
  2-stage revision  164 (34%)  9 (5%)  98%  1  –  –
  1-stage revision    86 (18%)  8 (9%)  89%  1.6  0.6–4.2  0.4
  Major partial exchange    61 (12%)  26 (43%)  63%  9.0  4.2–19.5  < 0.001
  Minor partial exchange  178 (36%)  34 (19%)  80%  2.5  1.1–5.8  0.03
            
a Adjusted in the Cox model for sex, type of fixation, type of prosthesis, and age at revision. 
Table 3. Descriptive data on 2-stage revision, 1-stage revision, major partial 1-stage exchange (i.e. exchange of stem or cup), and minor 
partial 1-stage exchange (i.e. exchange of head and/liner) for infected THAs in the period 2002–2009
Type of revision  No. of  Mean age at  Females %  Mean duration of  Mean interval: operation
  revisions (%)  revision (years) a    operation (min) a  to revision (years) a
2-stage revision  164 (34%)  71 (10; 39–87)  49%  330 (94; 175–780) b  3.2 (3.5; 0.1–16.3)
1-stage revision    86 (18%)  73 (10; 42–89)  43%  168 (63; 70–380)    p < 0.001  3.7 (3.7; 0.2–14.9)    p = 1.00
Major partial exchange    61 (13%)  71 (13; 31–89)  48%  139 (48; 40–265)    p < 0.001  3.7 (4.3; 0.0–19.0)    p = 1.00
Minor partial exchange  178 (36%)  71 (11; 38–89)   53%  95 (34; 35–320)      p < 0.001  0.7 (2.0;0.0–13.1)     p < 0.001 
Total  489 (100%)  71 (10; 38–89)  50%  197 (121; 35–780 )  2.5 (3.5; 0.0–19.0) 
a Values are mean (SD; min–max)
b The duration of operation for 2-stage revision includes first stage with removal of the implant (179 (64; 45–445)) and second stage with re-
implantation (151 (52; 70–450)).
Figure 5. Cox-adjusted survival curves for first revision due to infected THA for 2002–2009 with any reason for re-revision (panel A) and infection 
(panel B) as endpoints in the analyses for 2-stage revision, 1-stage revision, major partial 1-stage exchange (i.e. exchange of stem or cup), and 
minor partial 1-stage exchange (i.e. exchange of head and/or liner) .
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Cox analyses, we found no difference in the risk of re-revision 
for those revised with cemented implants (RR = 1.3 (0.8–2.0), 
p = 0.3). We obtained similar results using infection as end-
point (RR = 0.98 (0.5–1.9), p = 1.0).
During  the  period  2002–2009,  107  revisions  were  per-
formed with uncemented prostheses and 87 with antibiotic-
loaded cement. With any reason for re-revision as endpoint in 
the Cox analyses, the procedures performed with antibiotic-
loaded cement had a risk ratio for re-revision of 1.1 (0.5–2.5) 
compared to uncemented prostheses (p = 0.8). With infection 
as endpoint, the risk ratio for re-revision was 1.1 (0.4–3.1) 
(p = 0.8). 
Time interval between primary THA and revision
Recently, there has been interest in the time interval between 
the primary THA and the revision due to infection. We there-
fore conducted separate analyses for the period 2002–2009 for 
revisions performed less than 3 weeks after the primary THA 
(73 revisions, 15%), 3–12 weeks after the primary THA (101 
revisions, 21%), and more than 12 weeks after the primary 
THA (315 revisions, 64%). In the Cox analysis, either with 
any reason for revision or with infection as endpoint, no effect 
of the time interval between the primary operation and revi-
sion on the outcome of the revision was found, either for all 
procedures as a group or when the analyses were performed 
stratified for 2-stage, 1-stage, major, or minor partial revision 
procedures. 
Discussion
Revision rate due to infection after primary THA of 0.7% and 
2-year Kaplan-Meier survival of 92% for 2-stage exchange 
procedure  and  of  88%  for  1-stage  exchange  procedure  is 
acceptable for a whole nation. 2-year Kaplan-Meier survival 
of 76% for the far less extensive surgical procedure, minor 
partial revision, was only slightly inferior. This simpler pro-
cedure—both for the patient and for the health system, with 
only a slightly increased risk of re-revision—might therefore 
be an attractive low-morbidity option for periprosthetic hip 
infection.
In this national surveillance study, 9.5% of all first revisions 
were performed due to infection. In a large, nationally rep-
resentative population-based study of 51,345 revision THA 
procedures in the USA, 15% were done because of infection 
(Bozic et al. 2009).
Our investigation was a national, prospective observational 
study and the treatment of the reported infected THAs was not 
randomized with respect to the 4 different surgical procedures. 
Thus, the treatments are based on the surgeons’ and the hospi-
tals’ experience, knowledge, and strategies. The 2-stage pro-
cedure tended to be used when there were more severe infec-
tions, and the debridement with retention of the fixed implant 
(minor revision) tended to be used in the less severe cases. 
Our finding of 92% survival for the 2-stage procedure is in 
accordance with what is written in the literature (Stockley et 
al. 2008, Biring et al. 2009). Medical and surgical treatments 
are chosen individually by the treating surgeons on the basis 
of the different clinical settings. In the clinical setting, how-
ever, direct comparisons of these different surgical procedures 
are not appropriate since they tend to be used for different 
clinical indications. 
In Norway, a 2-stage surgical procedure is usually chosen for 
the most severe infections. The best results for this procedure 
are therefore convincing. However, 2-stage surgery requires 
a substantial period of reduced mobility for the patient, and 
the total duration of surgery (removal and re-insertion of the 
implant) is approximately twice that of the other procedures 
(Tables 1 and 3). The removal of a soundly fixed prosthesis 
may also result in degradation of the bone stock and periop-
erative fracture (Stockley et al. 2008, Biring et al. 2009, Fink 
2009). 
In recent years, the simpler procedure, with aggressive sur-
gical debridement and exchange of modular parts of the pros-
thesis, has become more popular in Norway (Figure 2) which 
is in accordance with experience in the literature (Giulieri et 
al. 2004, Trebse et al. 2005, Toms et al. 2006, Marculescu et 
al. 2006). This procedure is recommended in patients with a 
short history of infection (2–5 weeks), intact soft tissues (no 
fistulae), and bacteria that respond to biofilm antibiotics (Zim-
merli et al. 2004). The reported results of such early debride-
ment and implant retention vary from 30% eradication to 80% 
eradication of the infection (Azzam et al. 2010). In the present 
study, 76% of patients treated with debridement and retention 
did not have any further reported revisions to their hips during 
the 2 years of follow-up. Since we do not have follow-up data 
other than for revision surgery, the 76% does not represent the 
eradication rate. Some patients may still have had their infec-
tion but had not, for some reason, been re-revised. 
During recent years in Norway, there has been an increase 
in the reported number of revisions of infected THAs (Dale 
et  al.  2009, Walenkamp  2009).  Since  revisions  of  monob-
lock  prostheses—without  removing  or  exchanging  part  of 
the implant—are not reported to the registry, only revisions 
with removal or exchange of the whole or part of the prosthe-
sis are covered by the reporting requirements. With modular 
prostheses, which nowadays represent more than 90% of the 
femoral stems, easily removable parts such as head and liner 
are exchanged and the operation is then reported to the regis-
try as a revision. In the period under study, from 1987–2009, 
practically all uncemented THAs performed in Norway were 
modular  (Norwegian Arthroplasty  Register, Annual  Report 
2009). Of the cemented prostheses, about 20% were modu-
lar at the beginning of the period, but this proportion steadily 
increased to 90% at the end of the period. Partial exchange 
revision has thus been more feasible, which may have contrib-
uted to the dramatic increase in partial 1-stage exchange revi-
sion since 2000, as shown in Figure 2. This increase in minor 536  Acta Orthopaedica 2011; 82 (5): 530–537
partial 1-stage exchange revision could then partially explain 
the reported increase in revision for infection in Norway (Dale 
et al. 2009, Walenkamp 2009).
Major partial exchange, i.e. exchange of the stem or cup, 
takes about the same operating time as 1-stage exchange of 
the whole implant, but with inferior results. Thus, our findings 
do not support exchange of just the stem or cup in revision of 
an infected THA. 
60% of all re-revisions were performed because of infec-
tions, which is in accordance with what has been published 
(Jafari et al. 2010). For those revised with 2-stage revision this 
percentage was 39% while for 1-stage revision 56%, for major 
partial 58% and for minor partial 85% (Table 2). Accordingly, 
it appears to be more difficult to eradicate the infection with a 
single-stage procedure.
Uncemented implants have been recommended for use in 
revision of infected THAs (Fink 2009, Winkler 2009). We 
were unable, however, to find any difference in the results 
for revisions performed with uncemented implants or with 
implants where antibiotic-loaded cements were used, either 
for the whole period or for 2002–2009. 
Microorganisms growing in biofilms on the implant are of 
vital importance in the pathogenesis of prosthetic joint infec-
tion (Trampuz and Zimmerli 2006). These biofilms render the 
infection both difficult to diagnose and difficult to eradicate 
(Moojen et al. 2010). Recommendations for partial exchange 
revision of infected THAs stress the importance of a short 
duration of signs or symptoms of infection (less than 3 weeks) 
after the onset of infection (Zimmerli et al. 2004). Although the 
interval in our analyses from primary THA to the first revision 
was not identical with the interval from symptoms of infection 
until revision, most postoperative joint infections are probably 
the result of peroperative contamination. In our analyses, the 
mean time interval between the primary surgery and the revi-
sion for infection was shorter for minor partial exchange (0.7 
years) than for the other procedures (2.9–3.1 years). Debride-
ment  with  implant  retention  procedures  gave  good  results. 
When we divided the interval between the primary operation 
and the revision procedure into 3 groups (< 3 weeks, 3–12 
weeks, and > 12 weeks, we were unable to detect any influence 
of the time interval on the results of the revision—either for the 
whole group or when stratified for the different types of surgi-
cal procedures. Biofilms probably become established after a 
few hours, and in that respect also, 3 weeks may be much too 
long an interval. In accordance with this is the finding from the 
Mayo Clinic that duration of symptoms prior to debridement of 
more than 7 days is a risk factor that is independently associ-
ated with treatment failure (Marculescu et al. 2006). 
In conclusion, the data in the Norwegian Arthroplasty Reg-
ister showed that the 2-stage exchange procedure gave the 
highest  survival  rates  after  infected  total  hip  arthroplasty. 
Debridement with implant retention procedures had a survival 
of 76% at 2 years, indicating that this is an attractive option 
in selected patients. Exchange of stem or cup alone gave poor 
results and cannot be recommended in the attempt to eradicate 
THA infection.
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